Animal studies and studies in human volunteers have failed to demonstrate systemic absorption of topically applied Ketoconazole; however due to the teratogenic nature of the active ingredient, Ketoconazole should only be used in pregnant or lactating woman if in the judgement of the treating physician, the expected benefits outweigh the potential risk.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
